Provenance Wealth Advisors’s InVivo Therapeutics Holdings Corp NVIV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q1
Sell
-1
Closed -$1 634
2023
Q4
$1 Hold
1
﹤0.01% 596
2023
Q3
$1 Buy
+1
New +$1 ﹤0.01% 485